Invest now

Natco Pharma Cash Flow Annual

BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01026 | Sector: Biotechnology & Drugs
826.10 -12.45 (-1.48%)Updated : 08 Sep 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Issuance( Retirement)of Debt Net 423.60-92.60195.70-241.00
Net Changein Cash 78.9049.60-61.5020.80
Cash Taxes Paid 397.70372.60286.30177.50
Net Income/ Starting Line 1,490.802,291.401,673.50861.90
Total Cash Dividends Paid -90.20-107.80-170.80-100.40
Changesin Working Capital 247.70-572.30-595.70-114.80
Cashfrom Operating Activities 1,768.301,696.801,211.60849.10
Cash Interest Paid 35.9017.6018.1014.20
Cashfrom Financing Activities 297.50-210.70-246.90-363.00
Issuance( Retirement)of Stock Net 0.007.30-253.70-7.40
Depreciation/ Depletion 206.60235.20186.80163.80
Other Investing Cash Flow Items Total -1,690.60-902.90-674.00-271.50
Capital Expenditures -391.10-511.60-358.70-205.60
period Type ----
Foreign Exchange Effects 94.80-22.006.5011.80
Non- Cash Items -176.80-257.50-53.00-61.80
Financing Cash Flow Items -35.90-17.60-18.10-14.20
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -2,081.70-1,414.50-1,032.70-477.10
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,982.50+16.50(0.84%)
1,399.50-28.50 (-2.00%)
1,245.45-21.85 (-1.72%)